Literature DB >> 35939545

Longitudinal Evolution of Cardiac Dysfunction in Heart Failure and Preserved Ejection Fraction With Normal Natriuretic Peptide Levels.

Hidemi Sorimachi1, Frederik H Verbrugge1,2,3, Kazunori Omote1, Massar Omar1, Masaru Obokata1, Yogesh N V Reddy1, Zi Ye1, Hector I Michelena1, Barry A Borlaug1.   

Abstract

Entities:  

Keywords:  heart atria; heart failure, diastolic; natriuretic peptides; pro-brain natriuretic peptide

Mesh:

Substances:

Year:  2022        PMID: 35939545      PMCID: PMC9366900          DOI: 10.1161/CIRCULATIONAHA.121.058592

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   39.918


× No keyword cloud information.
  5 in total

1.  Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction?

Authors:  Michele Senni; Sergio Caravita; Walter J Paulus
Journal:  Circulation       Date:  2019-07-29       Impact factor: 29.690

2.  Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.

Authors:  Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Sorin Pislaru; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-02-21       Impact factor: 29.983

3.  BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction.

Authors:  Sanjiv J Shah
Journal:  Eur Heart J       Date:  2022-05-21       Impact factor: 35.855

4.  Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality.

Authors:  Frederik H Verbrugge; Kazunori Omote; Yogesh N V Reddy; Hidemi Sorimachi; Masaru Obokata; Barry A Borlaug
Journal:  Eur Heart J       Date:  2022-05-21       Impact factor: 35.855

Review 5.  Evaluation and management of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.